Overview We are a clinical-stage biopharmaceutical company developing oral fixed-dose combination therapies and psychedelic-assisted treatments for serious chronic conditions. Our principal development priority is IHL-42X for obstructive sleep apnea. We are also evaluating the next clinical development plan for PSX-001 in generalized anxiety disorder and the potential for further development of IHL-675A in inflammatory conditions. Our aim is to offer patients additional treatment options where e...
expected 2026-11-24
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-09-25 | 2026-06-30 | 0001628280-26-063506 | EDGAR | 89K words |
| 2025-09-29 | 2025-06-30 | 0001213900-25-092837 | EDGAR | 87K words |
| 2024-09-30 | 2024-06-30 | 0001213900-24-082937 | EDGAR | 93K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001213900-26-015867 | EDGAR | 18K words |
| 2025-11-14 | 2025-09-30 | 0001213900-25-110299 | EDGAR | 14K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-043682 | EDGAR | 21K words |
| 2025-02-14 | 2024-12-31 | 0001213900-25-013783 | EDGAR | 22K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098421 | EDGAR | 16K words |
| 2024-05-15 | 2024-03-31 | 0001213900-24-043391 | EDGAR | 17K words |
| 2024-02-14 | 2023-12-31 | 0001213900-24-013611 | EDGAR | 17K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-09 | 0001213900-26-098213 | EDGAR | 1K words |
| 2026-08-25 | 0001213900-26-093244 | EDGAR | 1K words |
| 2026-08-11 | 0001213900-26-087493 | EDGAR | 1K words |
| 2026-07-23 | 0001213900-26-080622 | EDGAR | 1K words |
| 2026-03-27 | 0001213900-26-035161 | EDGAR | 1K words |
| 2026-03-25 | 0001213900-26-033842 | EDGAR | 1K words |
| 2026-03-18 | 0001213900-26-029761 | EDGAR | 2K words |
| 2026-03-17 | 0001213900-26-028661 | EDGAR | 1K words |
| 2026-03-12 | 0001213900-26-026645 | EDGAR | 1K words |
| 2026-03-12 | 0001213900-26-026644 | EDGAR | 4K words |
172 total filings indexed. 152 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001873875 |
| Ticker | IXHL |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.incannex.com.au |
| Listed | 2022-02-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IXHL (~200 tokens, structured JSON with cryptographic provenance)